Table 1 The association between the clinicopathological characteristics and risk score in BRCA.
|  | RISK | 总计 | Pearson X2 | P-value | |
|---|---|---|---|---|---|
High | Low | ||||
Age | |||||
< 65 | 381 | 352 | 733 | 0.292 | 0.589 |
≥ 65 | 158 | 157 | 315 |  |  |
All | 539 | 509 | 1048 | Â | Â |
TNBC | |||||
+ | 83 | 29 | 112 | 28.795 | 8.05E-08 |
− | 388 | 436 | 824 |  |  |
All | 471 | 465 | 936 | Â | Â |
ER | |||||
+ | 345 | 425 | 770 | 58.514 | 2.02E-14 |
− | 171 | 62 | 233 |  |  |
All | 516 | 487 | 1003 | Â | Â |
PR | |||||
+ | 282 | 389 | 671 | 76.424 | 2.29E-18 |
− | 235 | 94 | 329 |  |  |
All | 517 | 483 | 1000 | Â | Â |
HER2 | |||||
+ | 99 | 54 | 153 | 9.73 | 0.001813 |
− | 273 | 268 | 541 |  |  |
All | 372 | 322 | 694 | Â | Â |
Stage | |||||
1–2 | 382 | 391 | 773 | 5.244 | 0.022 |
3–4 | 146 | 107 | 253 |  |  |
All | 528 | 498 | 1026 | Â | Â |
T | |||||
1–2 | 455 | 425 | 880 | 0.035 | 0.851 |
3–4 | 84 | 81 | 165 |  |  |
All | 539 | 506 | 1045 | Â | Â |
N | |||||
0 | 243 | 251 | 494 | 1.705 | 0.192 |
1–3 | 286 | 251 | 537 |  |  |
All | 529 | 502 | 1031 | Â | Â |
M | |||||
0 | 455 | 418 | 873 | 2.507 | 0.113 |
1 | 14 | 6 | 20 | Â | Â |
All | 469 | 424 | 893 | Â | Â |
